川芎嗪注射液联合尼可地尔治疗急性心力衰竭的临床效果

Abstract
Figure/Table
References (18)
Related Citation (15)

Download: PDF (439 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of Ligustrazine Injection on acute heart failure and its effect on cardiac function and hemodynamics. Methods A total of 115 patients with acute heart failure treated in No.909 Hospital of the Joint Logistics Support Force of the PLA and Zhangzhou Hospital Affiliated to Fujian Medical University from June 2018 to June 2021 were divided into Ligustrazine group(58 cases)and control group(57 cases)according to random number table method. The patients in the control group were treated with routine treatment, and the patients in the Ligustrazine group were treated with routine treatment plus Ligustrazine Injection. The clinical efficacy, cardiac function and hemodynamic indexes of the two groups were compared before and after 10 d of treatment. Results The total effective rate in the Ligustrazine group was higher than that in the control group, and the difference was statistically significant(P<0.05). After treatment, the left ventricular end diastolic and systolic diameters of the two groups were shorter than those of before treatment, the left ventricular ejection fraction and stroke output of the two groups were higher than those before treatment, and the left ventricular end diastolic and systolic diameters of the Ligustrazine group were shorter than those of the control group, the left ventricular ejection fraction and stroke output of the Ligustrazine group were higher than those of the control group, the differences were statistically significant (P<0.05). After treatment, the mean pulmonary artery pressure, central venous pressure, systemic circulation resistance and pulmonary circulation resistance of the two groups were lower than those before treatment, and the indexes of the Ligustrazine group were lower than those of the control group, and the differences were statistically significant (P<0.05). Conclusion Ligustrazine Injection is effective in the treatment of acute heart failure. It can effectively improve the indexes of cardiac function and hemodynamics in patients with acute heart failure, and it′s worthy of further study.

Key words： Acute heart failure Ligustrazine Cardiac function Hemodynamics

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I13/40

[5]	中华医学会心血管病学分会，中华心血管病杂志编辑委员会.急性心力衰竭诊断和治疗指南（二）[J].全科医学临床与教育，2010，8（6）：605-615.
[6]	刘国仗，吴宁，胡大一，等.心血管药物临床试验评价方法的建议[J].中华心血管病杂志，1998，26（6）：5-13.
[7]	中华医学会，中华医学会杂志社，中华医学会全科医学分会，等.急性心力衰竭基层诊疗指南（实践版·2019）[J].中华全科医师杂志，2019，18（10）：931-935.
[2]	史秀霞，田丽，吕丹.心力衰竭患者及照顾者接受姑息治疗的效果评价[J].广东医学，2019，40（7）：967-971.
[3]	李嘉，张成，杨广，等.盐酸川芎嗪联合丁苯酞对脑梗死临床疗效观察及安全性分析[J].华南国防医学杂志，2020，34（2）：92-95.
[4]	王晓会.阿托伐他汀钙联合丹参川芎嗪注射液治疗冠心病心绞痛的临床疗效及对血清Fractalkine 和血小板活化因子水平的影响[J].广西医科大学学报，2019，36（3）：435-438.
[1]	陈玉国，朱继红，裴红红，等.中国急诊急性心力衰竭单元建设与管理专家共识[J].中国急救医学，2019，39（6）：532-537.
[8]	程宏基，黄裕立，黄伟俊，等.急性心力衰竭患者远期死亡的预测因素分析[J].中国动脉硬化杂志，2020，28（12）：1060-1064.
[9]	孙润民，王琼英，齐苗苗，等.急性心肌梗死后心力衰竭预测因素的研究进展[J].中华心血管病杂志，2019，47（11）：923-926.
[10]	洪芳，滕龙，何建成.中西药在慢性心力衰竭治疗中相互作用研究的进展[J].心血管康复医学杂志，2020，29（2）：253-255.
[11]	李娇，郭静，李敏，等.川芎嗪对补体旁路激活致内皮细胞炎症反应的干预作用[J].中国药理学通报，2019，35（1）：90-95.
[12]	冯丹，高慎硕，刘兴基，等.单独使用川芎嗪和联用维生素C 对心肌缺血再灌注损伤保护作用的研究[J].泰山医学院学报，2019，40（5）：342-346.
[13]	王磊，陈韵岱，田峰.尼可地尔在冠心病治疗中的应用现状及研究进展[J].中西医结合心脑血管病杂志，2020，18（9）：1400-1402.
[14]	王鑫，马宏恩，吕晓燕，等.托拉塞米联合川芎嗪注射液治疗慢性心力衰竭的疗效及对患者血清MCP-1，BNP，NGAL 水平的影响[J].现代生物医学进展，2019，19（17）：3326-3329，3400.
[15]	李莉，张海霞.盐酸川芎嗪注射液联合替格瑞洛治疗冠心病心绞痛的临床研究[J].现代药物与临床，2020，35（10）：1968-1972.
[16]	曹梦灵，孙春金，关宏锏，等.T 淋巴细胞亚群在心力衰竭中的作用机制及诊疗进展[J].中国心血管病研究，2021，19（2）：164-168.
[17]	Tang WHW，Li DY，Hazen SL.Dietary metabolism，the gut microbiome，and heart failure[J].Nat Rev Cardiol，2019，16（3）：137-154.
[18]	张伟民，李瑞芳，付银峰，等.川芎嗪对阿霉素诱导的急性心衰小鼠心肌损伤和凋亡的保护作用[J].中国临床药理学杂志，2014，30（8）：708-711.